scholarly article | Q13442814 |
P2093 | author name string | Rong Jin | |
Guohong Li | |||
Min Wang | |||
Jarvis Li | |||
Adam Y Xiao | |||
P2860 | cites work | Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia. | Q47919801 |
Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke | Q48092753 | ||
Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination | Q48347152 | ||
Involvement of phosphoinositide 3-kinase gamma in the neuro-inflammatory response and cognitive impairments induced by beta-amyloid 1-40 peptide in mice | Q48373086 | ||
Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage | Q48384211 | ||
Resolving Thromboinflammation in the Brain After Ischemic Stroke? | Q48761468 | ||
Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. | Q50308473 | ||
Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. | Q52587502 | ||
The absence of functional PI3Kgamma prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice. | Q54684259 | ||
Thrombectomy for Acute Ischemic Stroke: Recent Insights and Future Directions | Q57175027 | ||
Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat | Q57179001 | ||
Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke | Q58713675 | ||
Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion | Q72157165 | ||
Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats | Q73563868 | ||
Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke | Q73718399 | ||
Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke | Q73746642 | ||
Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion | Q80553678 | ||
Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset | Q26796477 | ||
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke | Q29619330 | ||
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association | Q30238784 | ||
Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats | Q30826562 | ||
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials | Q31048053 | ||
MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. | Q33322709 | ||
Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. | Q33684529 | ||
Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years | Q33966207 | ||
Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke | Q35086740 | ||
Phosphoinositide 3-kinase-gamma expression is upregulated in brain microglia and contributes to ischemia-induced microglial activation in acute experimental stroke | Q35202539 | ||
Platelet–leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke | Q35633718 | ||
Platelet PI3Kγ Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions | Q35656802 | ||
Phosphoinositide 3-Kinase Gamma Contributes to Neuroinflammation in a Rat Model of Surgical Brain Injury | Q35876779 | ||
Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke | Q35905986 | ||
The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes | Q35976619 | ||
Embolic middle cerebral artery occlusion (MCAO) for ischemic stroke with homologous blood clots in rats | Q36788142 | ||
Hypertension and experimental stroke therapies | Q37073438 | ||
NF‐κB and innate immunity in ischemic stroke | Q37252167 | ||
Microvascular protection is essential for successful neuroprotection in stroke. | Q38050820 | ||
Animal models of ischemic stroke and their application in clinical research | Q38546471 | ||
Thromboinflammation in Stroke Brain Damage | Q38703081 | ||
Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats | Q39791602 | ||
Alteplase Reduces Downstream Microvascular Thrombosis and Improves the Benefit of Large Artery Recanalization in Stroke. | Q40458860 | ||
Seizures and recovery from experimental brain damage | Q41405943 | ||
Extension of the thrombolytic time window with minocycline in experimental stroke. | Q41812595 | ||
Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion | Q42509508 | ||
Resistance to thromboembolism in PI3Kgamma-deficient mice. | Q43711871 | ||
Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia | Q43820256 | ||
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats | Q43901758 | ||
PI3K-γ inhibition ameliorates acute lung injury through regulation of IκBα/NF-κB pathway and innate immune responses | Q44300358 | ||
Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons | Q45007330 | ||
PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus | Q46674138 | ||
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. | Q46674143 | ||
Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes | Q46758917 | ||
Platelet CD40 Mediates Leukocyte Recruitment and Neointima Formation after Arterial Denudation Injury in Atherosclerosis-Prone Mice | Q47645034 | ||
P433 | issue | 1 | |
P921 | main subject | plasminogen | Q107129060 |
embolic stroke | Q107538662 | ||
P304 | page(s) | 206-216 | |
P577 | publication date | 2019-01-01 | |
P1433 | published in | Hypertension | Q5958695 |
P1476 | title | PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke | |
P478 | volume | 73 |